跳至主要内容
临床试验/NCT04799015
NCT04799015已完成4 期

A Randomized Study of Dexamethasone as Adjuvant Therapy for Acute Post-traumatic Headache

Montefiore Medical Center2 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2021年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
162
试验地点
2
主要终点
Frequency Moderate or Severe headache after Emergency Department (ED) discharge

研究概览

简要总结

This is a randomized study of intravenous metoclopramide + intravenous dexamethasone versus intravenous metoclopramide for patients with acute post-traumatic headache.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet International Classification of Headache Disorders criteria for acute post-traumatic headache as follows:
  • Traumatic injury to the head has occurred
  • Headache has developed within 7 days of injury to the head
  • Headache is not better accounted for by another diagnosis (e.g., migraine or tension-type headache)
  • The headache must be rated as moderate or severe in intensity at the time of initial evaluation

排除标准

  • More than ten days have elapsed since the head trauma
  • Headache has already been treated with an anti-dopaminergic medication
  • Medication allergies
  • Contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use of MAO inhibitors, and use of anti-rejection transplant medications

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo IV + metoclopramide 10mg IV

干预措施: Metoclopramide 10mg (Drug)

Dexamethasone

Experimental

Dexamethasone 10mg IV + metoclopramide 10mg IV

干预措施: Metoclopramide 10mg (Drug)

Dexamethasone

Experimental

Dexamethasone 10mg IV + metoclopramide 10mg IV

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Frequency Moderate or Severe headache after Emergency Department (ED) discharge

时间窗: Up to 48 hours after ED discharge

Headache intensity will be rated based on the International Headache Society (IHS) 4-point scale. Using this scale participants will verbalize whether their headache intensity is "severe," "moderate," "mild," or "none." The percentage of patients reporting a headache intensity level of either "moderate" or 'severe" will be summarized by study arm. Between-group difference along with 95% confidence intervals will be reported. Patients who use an analgesic or abortive headache medication during the 48 hour period will be considered an outcome failure and their results will not be included in the analysis.

次要结局

  • Sustained headache relief(48 hours after ED discharge)
  • Post concussive symptoms(7 days after ED discharge)
  • Use of Rescue medication(Duration of ED admission, up to 3-4 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验